SG Americas Securities LLC Takes $43,000 Position in Cutera, Inc. (NASDAQ:CUTR)

SG Americas Securities LLC bought a new position in Cutera, Inc. (NASDAQ:CUTR) during the 4th quarter, Holdings Channel.com reports. The firm bought 12,314 shares of the medical device company’s stock, valued at approximately $43,000.

Other hedge funds also recently made changes to their positions in the company. BlackRock Inc. grew its holdings in Cutera by 3.4% in the 3rd quarter. BlackRock Inc. now owns 2,683,549 shares of the medical device company’s stock worth $122,371,000 after acquiring an additional 88,370 shares during the last quarter. FMR LLC increased its holdings in Cutera by 7.5% during the 1st quarter. FMR LLC now owns 1,454,189 shares of the medical device company’s stock valued at $34,348,000 after purchasing an additional 100,931 shares during the period. Vanguard Group Inc. raised its position in Cutera by 8.0% during the 3rd quarter. Vanguard Group Inc. now owns 1,213,025 shares of the medical device company’s stock valued at $55,314,000 after purchasing an additional 89,675 shares during the last quarter. Gamco Investors INC. ET AL lifted its holdings in Cutera by 0.6% in the 3rd quarter. Gamco Investors INC. ET AL now owns 1,144,646 shares of the medical device company’s stock worth $6,891,000 after buying an additional 7,040 shares during the period. Finally, Point72 Asset Management L.P. purchased a new stake in Cutera in the 2nd quarter worth approximately $14,677,000. 90.70% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CUTR has been the topic of several research analyst reports. Stephens reissued an “overweight” rating and set a $10.00 target price on shares of Cutera in a research note on Friday, March 22nd. William Blair upgraded shares of Cutera from an “underperform” rating to a “market perform” rating in a report on Friday, March 22nd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Cutera has a consensus rating of “Hold” and an average price target of $14.75.

Cutera Stock Performance

Cutera stock opened at $1.95 on Monday. Cutera, Inc. has a fifty-two week low of $1.28 and a fifty-two week high of $23.66. The stock’s 50 day simple moving average is $2.09 and its two-hundred day simple moving average is $2.67. The stock has a market cap of $38.88 million, a price-to-earnings ratio of -0.27 and a beta of 1.66.

Cutera (NASDAQ:CUTR) last released its earnings results on Thursday, March 21st. The medical device company reported ($2.27) EPS for the quarter, missing analysts’ consensus estimates of ($1.20) by ($1.07). The firm had revenue of $49.54 million during the quarter, compared to the consensus estimate of $49.10 million. On average, analysts predict that Cutera, Inc. will post -5.88 earnings per share for the current year.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform.